Tallac Therapeutics

Last updated: September 15, 2024

Hong I. Wan, president, CEO
Hong I. Wan, president, CEO
USA | Funding: $88.2M (+)

Website: https://www.tallactherapeutics.com/

Tallac Therapeutics offers next generation immunotherapies for cancer patients.